Free Trial

Afya (NASDAQ:AFYA) Earns Sell Rating from Citigroup

Afya logo with Consumer Discretionary background

Citigroup reaffirmed their sell rating on shares of Afya (NASDAQ:AFYA - Free Report) in a research report released on Friday morning, MarketBeat Ratings reports. They currently have a $15.00 price target on the stock, down from their previous price target of $18.00.

AFYA has been the subject of several other research reports. JPMorgan Chase & Co. dropped their price objective on shares of Afya from $25.00 to $20.50 and set a "neutral" rating for the company in a research note on Friday, January 17th. The Goldman Sachs Group initiated coverage on shares of Afya in a research report on Tuesday, December 3rd. They issued a "sell" rating and a $16.00 price target for the company. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $18.00.

Check Out Our Latest Stock Analysis on Afya

Afya Stock Performance

NASDAQ:AFYA traded up $0.30 during mid-day trading on Friday, hitting $16.45. 85,630 shares of the stock were exchanged, compared to its average volume of 91,244. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.60 and a current ratio of 1.60. The firm's 50-day simple moving average is $15.80 and its 200 day simple moving average is $16.62. Afya has a fifty-two week low of $14.52 and a fifty-two week high of $22.24. The stock has a market capitalization of $1.54 billion, a price-to-earnings ratio of 13.27, a price-to-earnings-growth ratio of 0.27 and a beta of 0.90.

Institutional Trading of Afya

Institutional investors and hedge funds have recently made changes to their positions in the company. Cubist Systematic Strategies LLC boosted its holdings in shares of Afya by 136.9% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 35,254 shares of the company's stock valued at $622,000 after purchasing an additional 20,370 shares in the last quarter. Millennium Management LLC boosted its stake in Afya by 45.0% in the second quarter. Millennium Management LLC now owns 291,164 shares of the company's stock valued at $5,139,000 after buying an additional 90,383 shares in the last quarter. DekaBank Deutsche Girozentrale bought a new position in Afya in the third quarter valued at about $417,000. Lifestyle Asset Management Inc. raised its stake in Afya by 13.3% during the third quarter. Lifestyle Asset Management Inc. now owns 16,753 shares of the company's stock worth $286,000 after acquiring an additional 1,969 shares in the last quarter. Finally, Quantbot Technologies LP lifted its holdings in shares of Afya by 73.8% in the third quarter. Quantbot Technologies LP now owns 13,268 shares of the company's stock worth $226,000 after acquiring an additional 5,636 shares during the last quarter. Institutional investors own 88.02% of the company's stock.

Afya Company Profile

(Get Free Report)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.

Read More

Analyst Recommendations for Afya (NASDAQ:AFYA)

Should You Invest $1,000 in Afya Right Now?

Before you consider Afya, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Afya wasn't on the list.

While Afya currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines